Overview

A Study of Lurasidone HCl in Subjects With Schizophrenia

Status:
Completed
Trial end date:
2019-09-17
Target enrollment:
Participant gender:
Summary
The study evaluates the effectiveness and safety of Lurasidone in subjects with schizophrenia over a period of 6 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Standard Chem. & Pharm. Co., Ltd.
Treatments:
Lurasidone Hydrochloride